Civil No. 13–13061–FDS. 05-22-2014 BIOGEN IDEC MA, INC., Plaintiff, v. JAPANESE FOUNDATION FOR CANCER RESEARCH and Bayer Pharma AG, Defendants. E. Anthony Figg, R. Danny Huntington, Seth E. Cockrum, Sharon E. Crane, Rothwell, Figg, Ernst & Manbeck P.C., Washington, DC, Claire Laporte, Donald R. Ware, Foley Hoag LLP, Boston, MA, for Plaintiff. Nels Lippert, Tarter, Krinsky & Drogin LLP, Paula Estrada De Martin, S. Calvin Walden, Wilmer Culter Pickering Hale and Dorr LLP, New York, NY, Elisabeth M
This chapter shall not be construed in any way to infringe on the rights of citizens under the state constitution or the constitution of the United States in the use of language in activities or functions conducted in the private sector. No agency or officer of the state or of any political subdivision of the state shall place any restrictions or requirements regarding language usage for businesses operating in the private sector other than in official documents, forms, submissions, or other communications
I.Any pooled risk management program meeting the standards required under this chapter is not an insurance company, reciprocal insurer, or insurer under the laws of this state, and administration of any activities of the plan shall not constitute doing an insurance business for purposes of regulation or taxation. II.Any such program operating under this chapter, whether or not a body corporate, may sue or be sued; make contracts; hold and dispose of real property; and borrow money, contract debts
(a) In an appeal brief (§§ 41.37 , 41.67 , or 41.68 ) or at the initiation of a contested case (§ 41.101 ), and within 20 days of any change during the proceeding, a party must identify: (1) Its real party-in-interest, and (2) Each judicial or administrative proceeding that could affect, or be affected by, the Board proceeding. (b) For contested cases, a party seeking judicial review of a Board proceeding must file a notice with the Board of the judicial review within 20 days of the filing of the